Latest Commercialization News

Horseshoe Metals advances its Horseshoe Lights copper-gold project with mining approval secured, site mobilization underway, and new drilling planned to expand resources.

D3 Energy’s latest re-test of the RBD10 well in South Africa’s ER315 permit shows a remarkable 38% increase in gas flow, underscoring unique reservoir dynamics that could lower development costs.

TMK Energy has forged a strategic alliance with Beijing-based J-Energy to accelerate development planning for its Gurvantes XXXV Coal Seam Gas project in Mongolia, leveraging J-Energy’s technical expertise and Chinese market connections.

Askari Metals has completed technical due diligence on its Nejo Gold and Copper Project in Ethiopia, clearing a key hurdle ahead of acquisition settlement and setting the stage for maiden drilling campaigns.

EBR Systems has won final CMS approval for New Technology Add-On Payment reimbursement, paving the way for Medicare coverage of its innovative WiSE cardiac pacing system starting October 2025.

Perpetual Resources has raised $1.6 million to accelerate exploration of lithium and caesium deposits in Brazil, following promising initial drilling results at its Igrejinha project.

Stellar Resources has confirmed that large-scale X-Ray Transmission ore sorting trials at its Heemskirk Tin Project significantly increase tin head grade while reducing processing costs. The promising results are now shaping the project's Prefeasibility Study.

Firebird Metals has received a significant Expression of Interest from Taza Metal Technologies to purchase up to five of its energy-efficient kilns, potentially generating over US$10 million in revenue. This marks a key step in Firebird’s international commercial expansion and highlights its leadership in sustainable manganese processing technology.

Vitrafy Life Sciences reported strong FY25 progress with 75% sales growth, advanced cryopreservation technology development, and a robust cash position. The company outlines a clear commercialisation roadmap for FY26, including product launches and expanded U.S. operations.

Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.

Telix Pharmaceuticals has recast its historical financials from AUD to USD to better reflect its US-centric revenue streams and reports increased operating expenditure tied to recent acquisitions and growth initiatives.

TPG Telecom has completed its transformative Vocus acquisition, launching a $4.7 billion capital management plan that includes a $3 billion shareholder return, significant debt repayment, and strong FY25 financial guidance.